Biosynthesized silver nanoparticles regulate the iron status in the spleen of Plasmodium chabaudi-infected mice

Pharmacological Effects of Biosynthesis Silver Nanoparticles Utilizing Calotropis procera Leaf Extracts on Plasmodium berghei-Infected Liver in Experiment Mice

Introduction

Malaria caused by Plasmodium spp. is the most hazardous disease in the world. It is regarded as a life-threatening hematological disorder caused by parasites transferred to humans by the bite of Anopheles mosquitoes.

Purpose

Calotropis procera leaf extract combined with biosynthesized silver nanoparticles (CPLEAgNPs) to evaluate its antiplasmodium and hepatoprotective effects against P. berghei-induced infection in experimental mice.

Methods

The animal groups were divided into four groups: the first non-infected group was orally administered distilled water daily 7 days. The second group received an oral dose of 50 mg/kg of CPLE AgNPs. The third group received intraperitoneal injections of 105 P. berghei. The fourth group received of 105 P. berghei with 50 mg/kg CPLE AgNPs. All mice were anesthetized with CO2 and dissected for sample collection.

Results

This study of C. procera leaves showed that they contain chemically active substances, as shown by the amounts of phenols, flavonoids, and tannins. The antioxidant activity of the samples was assessed using 1.1-diphenyl-2-picrylhydrazyl (DPPH) and 2.2'-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid (ABTS) assays. Treatment of infected mice with CPLE AgNPs for 7 days resulted in a significant decrease in parasitemia and a reduction in histopathological alterations in the liver. Furthermore, CPLE AgNPs mitigated oxidative damage caused by P. berghei infection in the liver. In addition, after receiving the medication, the liver levels of alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase decreased. In addition, CPLE AgNPs regulated the expression of liver cytokines, including IL-1β, and I-10.

Discussion

Based on these findings, the study proved that CPLE AgNPs have hepatoprotective and antiplasmodial properties.

Exploring novel potential of mycosynthesized magnetic nanoparticles for phosphatase immobilization and biological activity

Among different microbes, fungi are proficient candidates for the extracellular synthesis of iron nanoparticles. For biogenic synthesis of iron nanoparticles, a thermophilic mould Myceliophthora thermophila BJTLRMDU7 was used in this study. Mycogenic magnetic nanoparticles were used for phosphatase immobilization and therapeutic applications such as antimicrobial and antimalarial activity. Firstly, the phosphatase was immobilized on biogenic iron nanoparticles with an efficiency of >56 %. Immobilized enzyme was optimally active at 60 °C and pH 5. Immobilized phosphatase was recycled using external magnetic field up to 4th cycle retaining >50 % activity. The immobilized phosphatase efficiently released inorganic phosphate from different flours such as wheat, maize and gram at 37 °C and 60 °C. There was continuous increase in the release of inorganic phosphorus from all samples with incubation time at 37 °C and slight reduction at 60 °C. These nanoparticles showed the effective antimicrobial activity against Bacillus subtilis, Escherichia coli and Myceliophthora thermophila. Further, the synthesized iron nanoparticles showed antimalarial potential against Plasmodium falciparum. Biogenic nanoparticles did not exhibit hemolytic activity and cytotoxicity. Therefore, biogenic iron nanoparticles could be used as a suitable matrix for immobilization of enzymes and safe therapeutics.

A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi

The study aimed to verify the pathogenic malarial kidney infections and histopathological pictures in mice infected with Plasmodium chabaudi using Indigofera oblongifolia leaf extract silver nanoparticles (IOLEAgNPs). Fifty healthy adult female mice C57BL/6 were used. Animals were divided into five groups, with each group of ten mice. The first control non-infected group was given distilled water for 7 days. The second group was orally given 50 mg/kg of IOLEAgNPs. The third, fourth, and fifth groups were injected intraperitoneally with 105 parasitized erythrocytes of P. chabaudi. After 1 h, the fourth group received 50 mg/kg of IOLEAgNPs, while the fifth group orally received 10 mg/kg chloroquine phosphate. The histopathology of the kidney was studied by routine histology method with hematoxylin-eosin staining. The kidney revealed cerebral microvessel congestion, hemorrhages, and necrosis. Cast formation, glomerulonephritis, tubular necrosis, and congestion were observed in the kidney cortex. Consequently, the targeted medical IOLEAgNPs reduced this degeneration impact on renal tissue. Proven that plant-source synthesized IOLEAgNPs play a preventive role as antimalarial agents in female mice infected with P. chabaudi.

Modular nanotheranostic agents for protistan parasitic diseases: Magic bullets with tracers

Protistan parasitic infections contribute significantly to morbidity and mortality, causing more than 2 billion human infections annually. However, current treatments are often limited; due to ineffective drugs and drug resistance, thus better options are urgently required. In the present context, theranostics agents are those that offer simultaneous detection, diagnosis and even treatment of protistan parasitic diseases. "Nanotheranostics" is the term used to describe such agents, that are around 100 nm or less in size. Anti-parasitic activity of nanoparticles (NPs) has been reported, and many have useful intrinsic imaging properties, but it is perhaps their multifunctional nature that offers the greatest potential. NPs may be used as adapters onto which various subunits with different functions may be attached. These subunits may facilitate targeting parasites, coupled with toxins to eradicate parasites, and probe subunits for detection of particles and/or parasites. The modular nature of nano-platforms promises a "mix and match" approach for the construction of tailored agents by using combinations of these subunits against different protistan parasites. Even though many of the subunits have shown promise alone, these have not yet been put together convincingly enough to form working theranostics against protistan parasites. Although the clinical application of nanotheranostics to protistan parasitic infections in humans requires more research, we conclude that they offer not just a realisation of Paul Ehrlich's long imagined "magic bullet" concept, but potentially are magic bullets combined with tracer bullets.

Biosynthesized nanosilver as anti-oxidant, anti-apoptotic and anti-inflammatory agent against Plasmodium chabaudi infection in the mouse liver

In recent years, the use of plant-mediated nanoparticle synthesis to combat infectious diseases has become increasingly significant. Malaria is one of the world's most infectious diseases caused by Plasmodium species. The antioxidant, anti-apoptotic, and anti-inflammatory properties of nanosilver biosynthesized from Indigofera oblongifolia leaf extracts (NS) against Plasmodium chabaudi infection of the mouse liver were investigated in this research. Male mice were infected with P. chabaudi infected erythrocytes then treated with NS for 7 days. The parasitemia was suppressed by approximately 24, 28, 47 and 75% on days 4, 5, 6 and 7 postinfection, respectively after treatment of mice with NS. Also, NS was able to regulate the leucocytes count and the IL1β and TNF-α-mRNA expression in mice. Ns could increase the antioxidant activity in liver of mice and was able to regulate the apoptotic genes, Bcl2 and Casp3. We showed that NS has antioxidant, anti-apoptotic, and anti-inflammatory properties when it was used to treat the livers of mice infected with P. chabaudi.

Medicinal plants as a fight against murine blood-stage malaria

OBJECTIVE

Malaria is an infectious parasitic disease affecting most of countries worldwide. Due to antimalarial drug resistance, researchers are seeking to find another safe efficient source for treatment of malaria. Since many years ago, medicinal plants were widely used for the treatment of several diseases. In general, most application is done first on experimental animals then human. In this article, medicinal plants as antimalarial agents in experimental animals were reviewed from January 2000 until November 2020.

MATERIALS AND METHODS

In this systematic review published articles were reviewed using the electronic databases NCBI, ISI Web of knowledge, ScienceDirect and Saudi digital library to check articles and theses for M.Sc/Ph.D. The name of the medicinal plant with its taxon ID and family, the used Plasmodium species, plant part used and its extract type and the country of harvest were described.

RESULTS AND CONCLUSION

The reviewed plants belonged to 83 families. Medicinal plants of families Asteraceae, Meliaceae Fabaceae and Lamiaceae are the most abundant for use in laboratory animal antimalarial studies. According to region, published articles from 33 different countries were reviewed. Most of malaria published articles are from Africa especially Nigeria and Ethiopia. Leaves were the most common plant part used for the experimental malaria research. In many regions, research using medicinal plants to eliminate parasites and as a defensive tool is popular.

Plasmodium chabaudi-infected mice spleen response to synthesized silver nanoparticles from Indigofera oblongifolia extract

Malaria is a worldwide serious-threatening infectious disease caused by Plasmodium and the parasite resistance to antimalarial drugs has confirmed a significant obstacle to novel therapeutic antimalarial drugs. In this article, we assessed the antioxidant and anti-inflammatory activity of nanoparticles prepared from Indigofera oblongifolia extract (AgNPs) against the infection with Plasmodium chabaudi caused in mice spleen. AgNPs could significantly suppress the parasitaemia caused by the parasite to approximately 98% on day 7 postinfection with P. chabaudi and could improve the histopathological induced spleen damage. Also, AgNPs were able to increase the capsule thickness of the infected mice spleen. In addition, the AgNPs functioned as an antioxidant agent that affects the change in glutathione, nitric oxide and catalase levels in the spleen. Moreover spleen IL1β, IL-6 and TNF-α-mRNA expression was regulated by AgNPs administration to the infected mice. These results indicated the anti-oxidant and the anti-inflammatory protective role of AgNPs against P. chabaudi-induced spleen injury.